04/06/2026
A recent study found that combining GLP-1 drugs with healthful habits significantly reduces serious cardiovascular event risk
-
Use of blockbuster anti-obesity drugs like Wegovy and Zepbound is growing, with about 1 in 8 adults in the U.S. saying they currently take the medications.